Immunitybio

IBRX • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $40 $139 $82 $41
Gross Profit -4,515 -4,425 -4,503 -6,277
EBITDA -90,641 -79,939 -80,136 -90,884
EBIT -95,196 -84,503 -84,721 -95,566
Net Income -134,109 -233,392 -95,582 -137,879
Net Change In Cash 40 139 82 41
Cost of Revenue -44,965
Free Cash Flow -108,246 -123,226 -93,078 -88,299
Cash 133,035 265,452 177,963 43,506
Basic Shares 672,831 670,867 498,375 437,456

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $622 $240 $934 $605
Gross Profit -17,890 -23,952 934 -8,542
EBITDA -342,852 -343,978 -316,304 -195,128
EBIT -361,364 -351,298 -330,280 -220,880
Net Income -583,196 -417,320 -349,848 -224,187
Net Change In Cash 622 240 934 605
Cost of Revenue -76,599 146,138 -4,067
Free Cash Flow -397,341 -436,900 -307,982 -173,393
Cash 265,452 104,641 181,101 34,915
Basic Shares 508,635 399,900 389,234 383,179

Earnings Calls

Quarter EPS
2023-12-31 -$0.35
2023-09-30 -$0.19
2023-06-30 -$0.32
2023-03-31 -$0.27